JACQUELINE K. BARTON - 12 May 2021 Form 4 Insider Report for GILEAD SCIENCES INC (GILD)

Role
Director
Signature
/s/ Amy Kim by Power of Attorney for Jacqueline K. Barton
Issuer symbol
GILD
Transactions as of
12 May 2021
Transactions value $
$0
Form type
4
Filing time
14 May 2021, 16:27:17 UTC
Previous filing
07 May 2021
Next filing
03 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Award +2,223 +48.82% 6,776 12 May 2021 Common Stock 2,223 Direct F1, F2
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +14,665 $0 14,665 12 May 2021 Common Stock 14,665 $67.45 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 100% of the restricted stock units will vest on the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting.
F3 25% of the shares subject to the option vest on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting.